The global Sexually Transmitted Diseases (STD) Diagnostics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Sexually Transmitted Diseases (STD) Diagnostics Industry Forecast” looks at past sales and reviews total world Sexually Transmitted Diseases (STD) Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Sexually Transmitted Diseases (STD) Diagnostics sales for 2023 through 2029.

With Sexually Transmitted Diseases (STD) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sexually Transmitted Diseases (STD) Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Sexually Transmitted Diseases (STD) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Sexually Transmitted Diseases (STD) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sexually Transmitted Diseases (STD) Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sexually Transmitted Diseases (STD) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sexually Transmitted Diseases (STD) Diagnostics.

The United States market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

The China market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

The Europe market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Sexually Transmitted Diseases (STD) Diagnostics players cover:

• F.Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Hologic Inc.
• Creative Diagnostics
• Abbott Laboratories

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of the Sexually Transmitted Diseases (STD) Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Molecular Test
• Serologic Test
• Point of Care Test
• Others

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• F.Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Hologic Inc.
• Creative Diagnostics
• Abbott Laboratories
• Quest Diagnostics
• BD
• QIAGEN
• Cepheid
• bioMerieux Inc.